Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs.

Orditura M, Della Corte CM, Diana A, Ciaramella V, Franzese E, Famiglietti V, Panarese I, Franco R, Grimaldi A, Lombardi A, Caraglia M, Santoriello A, Procaccini E, Lieto E, Maiello E, De Vita F, Ciardiello F, Morgillo F.

Breast. 2018 Aug 4;41:165-171. doi: 10.1016/j.breast.2018.08.002. [Epub ahead of print]

PMID:
30103105
2.

Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis.

Ventriglia J, Petrillo A, Huerta Alváro M, Laterza MM, Savastano B, Gambardella V, Tirino G, Pompella L, Diana A, Iovino F, Troiani T, Martinelli E, Morgillo F, Orditura M, Cervantes A, Ciardiello F, De Vita F.

Gastroenterol Res Pract. 2018 Jun 10;2018:2373868. doi: 10.1155/2018/2373868. eCollection 2018.

3.

Systemic-inflammation-based score can predict prognosis in metastatic gastric cancer patients before first-line chemotherapy.

Petrillo A, Laterza MM, Tirino G, Pompella L, Ventriglia J, Pappalardo A, Famiglietti V, Martinelli E, Ciardiello F, Orditura M, Galizia G, De Vita F.

Future Oncol. 2018 Jul 3. doi: 10.2217/fon-2018-0167. [Epub ahead of print]

PMID:
29969285
4.

Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24).

Farolfi A, Petrone M, Scarpi E, Gallà V, Greco F, Casanova C, Longo L, Cormio G, Orditura M, Bologna A, Zavallone L, Ventriglia J, Franzese E, Loizzi V, Giardina D, Pigozzi E, Cioffi R, Pignata S, Giorda G, De Giorgi U.

Target Oncol. 2018 Jun 14. doi: 10.1007/s11523-018-0574-1. [Epub ahead of print]

PMID:
29948780
5.

Trabectedin in Ovarian Cancer: is it now a Standard of Care?

Ventriglia J, Paciolla I, Cecere SC, Pisano C, Di Napoli M, Arenare L, Setola SV, Losito NS, Califano D, Orditura M, Pignata S.

Clin Oncol (R Coll Radiol). 2018 Aug;30(8):498-503. doi: 10.1016/j.clon.2018.01.008. Epub 2018 Feb 9.

PMID:
29429842
6.

Indocyanine Green Fluorescence Imaging-Guided Surgery in Primary and Metastatic Liver Tumors.

Lieto E, Galizia G, Cardella F, Mabilia A, Basile N, Castellano P, Orditura M, Auricchio A.

Surg Innov. 2018 Feb;25(1):62-68. doi: 10.1177/1553350617751451. Epub 2018 Jan 5.

PMID:
29303061
7.

Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment.

Martinelli E, Sforza V, Cardone C, Capasso A, Nappi A, Martini G, Napolitano S, Rachiglio AM, Normanno N, Cappabianca S, Reginelli A, Bisceglie MD, Latiano TP, Maiello E, Orditura M, De Vita F, Morgillo F, Ciardiello F, Troiani T.

ESMO Open. 2017 Jul 29;2(3):e000177. doi: 10.1136/esmoopen-2017-000177. eCollection 2017.

8.

Propensity score-matched comparison between complete mesocolic excision and classic right hemicolectomy for colon cancer.

Lieto E, Abdelkhalek M, Orditura M, Denewer A, Castellano P, Youssef TF, Auricchio A, Setit A, Galizia G.

Minerva Chir. 2018 Feb;73(1):1-12. doi: 10.23736/S0026-4733.17.07451-X. Epub 2017 Nov 20.

PMID:
29154513
9.

Naples Prognostic Score, Based on Nutritional and Inflammatory Status, is an Independent Predictor of Long-term Outcome in Patients Undergoing Surgery for Colorectal Cancer.

Galizia G, Lieto E, Auricchio A, Cardella F, Mabilia A, Podzemny V, Castellano P, Orditura M, Napolitano V.

Dis Colon Rectum. 2017 Dec;60(12):1273-1284. doi: 10.1097/DCR.0000000000000961.

PMID:
29112563
10.

Phosphatidylinositol 3-kinase (PI3Kα)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells.

Morgillo F, Della Corte CM, Diana A, Mauro CD, Ciaramella V, Barra G, Belli V, Franzese E, Bianco R, Maiello E, de Vita F, Ciardiello F, Orditura M.

Oncotarget. 2017 Aug 22;8(44):76479-76491. doi: 10.18632/oncotarget.20385. eCollection 2017 Sep 29.

11.

Efficacy of a triplet and doublet-based chemotherapy as first-line therapy in patients with HER2-negative metastatic gastric cancer: a retrospective analysis from the clinical practice.

Laterza MM, Pompella L, Petrillo A, Tirino G, Pappalardo A, Orditura M, Troiani T, Ciardiello F, Di Martino N, De Vita F.

Med Oncol. 2017 Oct 17;34(11):186. doi: 10.1007/s12032-017-1046-7.

PMID:
29043514
12.

Fluorescence-Guided Surgery in the Combined Treatment of Peritoneal Carcinomatosis from Colorectal Cancer: Preliminary Results and Considerations.

Lieto E, Auricchio A, Cardella F, Mabilia A, Basile N, Castellano P, Orditura M, Galizia G.

World J Surg. 2018 Apr;42(4):1154-1160. doi: 10.1007/s00268-017-4237-7.

PMID:
28929277
13.

Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trial.

Martinelli E, Cardone C, Troiani T, Normanno N, Pisconti S, Sforza V, Bordonaro AR, Rachiglio AM, Lambiase M, Latiano TP, Modoni G, Cordio S, Giuliani F, Biglietto M, Montesarchio V, Barone C, Tonini G, Cinieri S, Febbraro A, Rizzi D, De Vita F, Orditura M, Colucci G, Maiello E, Ciardiello F.

ESMO Open. 2017 Feb 20;1(6):e000086. doi: 10.1136/esmoopen-2016-000086. eCollection 2016.

14.

Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial).

Orditura M, Gravina A, Riccardi F, Diana A, Mocerino C, Leopaldi L, Fabozzi A, Giordano G, Nettuno R, Incoronato P, Barzelloni ML, Caputo R, Pisano A, Grimaldi G, Genua G, Montesarchio V, Barbato E, Iodice G, Lieto E, Procaccini E, Mabilia R, Febbraro A, Laurentiis M, Ciardiello F.

ESMO Open. 2017 Jun 2;2(2):e000176. doi: 10.1136/esmoopen-2017-000176. eCollection 2017.

15.

Preoperative Neutrophil to Lymphocyte Ratio and Lymphocyte to Monocyte Ratio are Prognostic Factors in Gastric Cancers Undergoing Surgery.

Lieto E, Galizia G, Auricchio A, Cardella F, Mabilia A, Basile N, Del Sorbo G, Castellano P, Romano C, Orditura M, Napolitano V.

J Gastrointest Surg. 2017 Nov;21(11):1764-1774. doi: 10.1007/s11605-017-3515-x. Epub 2017 Jul 27.

PMID:
28752404
16.

Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience.

Galizia G, Lieto E, Auricchio A, Cardella F, Mabilia A, Diana A, Castellano P, De Vita F, Orditura M.

PLoS One. 2017 Apr 5;12(4):e0173619. doi: 10.1371/journal.pone.0173619. eCollection 2017.

17.

Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: a propensity score-matched analysis.

Orditura M, Galizia G, Diana A, Saccone C, Cobellis L, Ventriglia J, Iovino F, Romano C, Morgillo F, Mosca L, Diadema MR, Lieto E, Procaccini E, De Vita F, Ciardiello F.

ESMO Open. 2016 Mar 7;1(2):e000038. eCollection 2016.

18.

Pancreatic stump closure after pancreatoduodenectomy in elderly patients: a retrospective clinical study.

Mauriello C, Polistena A, Gambardella C, Tartaglia E, Orditura M, De Vita F, Santini L, Avenia N, Conzo G.

Aging Clin Exp Res. 2017 Feb;29(Suppl 1):35-40. doi: 10.1007/s40520-016-0657-8. Epub 2016 Nov 11.

19.

NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice.

De Vita F, Ventriglia J, Febbraro A, Laterza MM, Fabozzi A, Savastano B, Petrillo A, Diana A, Giordano G, Troiani T, Conzo G, Galizia G, Ciardiello F, Orditura M.

BMC Cancer. 2016 Sep 2;16(1):709. doi: 10.1186/s12885-016-2671-9.

20.

Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX.

Ciardiello F, Normanno N, Martinelli E, Troiani T, Pisconti S, Cardone C, Nappi A, Bordonaro AR, Rachiglio M, Lambiase M, Latiano TP, Modoni G, Cordio S, Giuliani F, Biglietto M, Montesarchio V, Barone C, Tonini G, Cinieri S, Febbraro A, Rizzi D, De Vita F, Orditura M, Colucci G, Maiello E; CAPRI-GOIM Investigators; CAPRI-GOIM investigators.

Ann Oncol. 2016 Jun;27(6):1055-61. doi: 10.1093/annonc/mdw136. Epub 2016 Mar 21.

PMID:
27002107
21.

Pancreatic neuroendocrine tumors: Nosography, management and treatment.

Orditura M, Petrillo A, Ventriglia J, Diana A, Laterza MM, Fabozzi A, Savastano B, Franzese E, Conzo G, Santini L, Ciardiello F, De Vita F.

Int J Surg. 2016 Apr;28 Suppl 1:S156-62. doi: 10.1016/j.ijsu.2015.12.052. Epub 2015 Dec 18. Review.

22.

Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells.

Della Corte CM, Ciaramella V, Di Mauro C, Castellone MD, Papaccio F, Fasano M, Sasso FC, Martinelli E, Troiani T, De Vita F, Orditura M, Bianco R, Ciardiello F, Morgillo F.

Oncotarget. 2016 Jan 26;7(4):4265-78. doi: 10.18632/oncotarget.6559.

23.

Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review.

Mauriello C, Napolitano S, Gambardella C, Candela G, De Vita F, Orditura M, Sciascia V, Tartaglia E, Lanza M, Santini L, Conzo G.

Int J Surg. 2015 Sep;21 Suppl 1:S10-4. doi: 10.1016/j.ijsu.2015.04.089. Epub 2015 Jun 26. Review.

24.

Pancreatic fistula following pancreatoduodenectomy. Evaluation of different surgical approaches in the management of pancreatic stump. Literature review.

Conzo G, Gambardella C, Tartaglia E, Sciascia V, Mauriello C, Napolitano S, Orditura M, De Vita F, Santini L.

Int J Surg. 2015 Sep;21 Suppl 1:S4-9. doi: 10.1016/j.ijsu.2015.04.088. Epub 2015 Jun 26. Review.

25.

Reply "Modified D2 lymphadenectomy is effective in patients with node-positive gastric cancers undergoing potentially curative total gastrectomy".

Galizia G, Lieto E, Zamboli A, Auricchio A, Orditura M.

Surgery. 2015 Nov;158(5):1447-8. doi: 10.1016/j.surg.2015.04.018. Epub 2015 May 30. No abstract available.

PMID:
26036879
26.

Treatment of esophagogastric junction carcinoma: an unsolved debate.

Orditura M, Galizia G, Lieto E, De Vita F, Ciardiello F.

World J Gastroenterol. 2015 Apr 21;21(15):4427-31. doi: 10.3748/wjg.v21.i15.4427. Review.

27.

Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial.

Pignata S, Lorusso D, Scambia G, Sambataro D, Tamberi S, Cinieri S, Mosconi AM, Orditura M, Brandes AA, Arcangeli V, Panici PB, Pisano C, Cecere SC, Di Napoli M, Raspagliesi F, Maltese G, Salutari V, Ricci C, Daniele G, Piccirillo MC, Di Maio M, Gallo C, Perrone F; MITO 11 investigators.

Lancet Oncol. 2015 May;16(5):561-8. doi: 10.1016/S1470-2045(15)70115-4. Epub 2015 Apr 14.

PMID:
25882986
28.

Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: A propensity score-matched analysis.

Galizia G, Lieto E, Zamboli A, De Vita F, Castellano P, Romano C, Auricchio A, Cardella F, De Stefano L, Orditura M.

Surgery. 2015 Jul;158(1):112-20. doi: 10.1016/j.surg.2015.02.006. Epub 2015 Mar 25.

PMID:
25818659
29.

Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis.

Federico A, Orditura M, Cotticelli G, DE Sio I, Romano M, Gravina AG, Dallio M, Fabozzi A, Ciardiello F, Loguercio C, DE Vita F.

Oncol Lett. 2015 Apr;9(4):1628-1632. Epub 2015 Feb 12.

30.

Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case report.

Iovino F, Orditura M, Auriemma PP, Ciorra FR, Giordano G, Orabona C, Bara F, Sergio R, Savastano B, Fabozzi A, Laterza MM, Ventriglia J, Petrillo A, Della Corte CM, DE Vita F.

Oncol Lett. 2015 Mar;9(3):1403-1405. Epub 2014 Dec 23.

31.

CD26-positive/CD326-negative circulating cancer cells as prognostic markers for colorectal cancer recurrence.

Lieto E, Galizia G, Orditura M, Romano C, Zamboli A, Castellano P, Mabilia A, Auricchio A, DE Vita F, Gemei M.

Oncol Lett. 2015 Feb;9(2):542-550. Epub 2014 Dec 1.

32.

Does Preoperative Neutrophil to Lymphocyte Ratio Predict Disease-Free Survival Rate in Colorectal Cancer Patients Undergoing Curative Surgery?

Galizia G, Lieto E, Orditura M.

Ann Surg. 2016 Jun;263(6):e80. doi: 10.1097/SLA.0000000000001075. No abstract available.

PMID:
25575259
33.

Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis.

Galizia G, Lieto E, De Vita F, Castellano P, Ferraraccio F, Zamboli A, Mabilia A, Auricchio A, De Sena G, De Stefano L, Cardella F, Barbarisi A, Orditura M.

Surgery. 2015 Feb;157(2):285-96. doi: 10.1016/j.surg.2014.09.012. Epub 2014 Dec 19.

PMID:
25532433
34.

Clinical management of advanced gastric cancer: the role of new molecular drugs.

De Vita F, Di Martino N, Fabozzi A, Laterza MM, Ventriglia J, Savastano B, Petrillo A, Gambardella V, Sforza V, Marano L, Auricchio A, Galizia G, Ciardiello F, Orditura M.

World J Gastroenterol. 2014 Oct 28;20(40):14537-58. doi: 10.3748/wjg.v20.i40.14537. Review.

35.

Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial.

Ciardiello F, Normanno N, Maiello E, Martinelli E, Troiani T, Pisconti S, Giuliani F, Barone C, Cartenì G, Rachiglio AM, Montesarchio V, Tonini G, Rizzi D, Cinieri S, Bordonaro R, Febbraro A, De Vita F, Orditura M, Fenizia F, Lambiase M, Rinaldi A, Tatangelo F, Botti G, Colucci G.

Ann Oncol. 2014 Sep;25(9):1756-61. doi: 10.1093/annonc/mdu230. Epub 2014 Jun 18.

PMID:
24942275
36.

Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma-a pilot study.

Orditura M, Galizia G, Di Martino N, Ancona E, Castoro C, Pacelli R, Morgillo F, Rossetti S, Gambardella V, Farella A, Laterza MM, Ruol A, Fabozzi A, Napolitano V, Iovino F, Lieto E, Fei L, Conzo G, Ciardiello F, De Vita F.

Curr Oncol. 2014 Jun;21(3):125-33. doi: 10.3747/co.21.1570.

37.

Treatment of gastric cancer.

Orditura M, Galizia G, Sforza V, Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J, Savastano B, Mabilia A, Lieto E, Ciardiello F, De Vita F.

World J Gastroenterol. 2014 Feb 21;20(7):1635-49. doi: 10.3748/wjg.v20.i7.1635. Review.

38.

Mediastinal sarcoid-like reaction after colon adenocarcinoma resection.

Fiorelli A, Accardo M, Orditura M, Santini M.

Asian Cardiovasc Thorac Ann. 2015 Jan;23(1):82-4. doi: 10.1177/0218492313519805. Epub 2014 Jan 21.

PMID:
24585283
39.

Conversion chemotherapy followed by hepatic resection in colorectal cancer with initially unresectable liver-limited metastases.

Galizia G, De Vita F, Lieto E, Zamboli A, Morgillo F, Castellano P, Mabilia A, Auricchio A, Renda A, Ciardiello F, Orditura M.

Oncol Rep. 2013 Dec;30(6):2992-8. doi: 10.3892/or.2013.2795. Epub 2013 Oct 11.

PMID:
24126855
40.

Preoperative treatment of locally advanced esophageal carcinoma (Review).

Orditura M, Galizia G, Fabozzi A, Lieto E, Gambardella V, Morgillo F, Del Genio GM, Fei L, Di Martino N, Renda A, Ciardiello F, De Vita F.

Int J Oncol. 2013 Dec;43(6):1745-53. doi: 10.3892/ijo.2013.2118. Epub 2013 Oct 2. Review.

PMID:
24100679
41.

Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers? A prospective study.

Galizia G, Lieto E, De Vita F, Ferraraccio F, Zamboli A, Mabilia A, Auricchio A, Castellano P, Napolitano V, Orditura M.

Int J Colorectal Dis. 2014 Jan;29(1):89-97. doi: 10.1007/s00384-013-1766-x. Epub 2013 Aug 28.

PMID:
23982425
42.

Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer.

Morgillo F, De Vita F, Antoniol G, Orditura M, Auriemma PP, Diadema MR, Lieto E, Savastano B, Festino L, Laterza MM, Fabozzi A, Ventriglia J, Petrillo A, Ciardiello F, Barbarisi A, Iovino F.

Curr Oncol. 2013 Aug;20(4):e283-8. doi: 10.3747/co.20.1380.

43.

Postoperative detection of circulating tumor cells predicts tumor recurrence in colorectal cancer patients.

Galizia G, Gemei M, Orditura M, Romano C, Zamboli A, Castellano P, Mabilia A, Auricchio A, De Vita F, Del Vecchio L, Lieto E.

J Gastrointest Surg. 2013 Oct;17(10):1809-18. doi: 10.1007/s11605-013-2258-6. Epub 2013 Jun 28.

PMID:
23813048
44.

Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines.

Morgillo F, Sasso FC, Della Corte CM, Vitagliano D, D'Aiuto E, Troiani T, Martinelli E, De Vita F, Orditura M, De Palma R, Ciardiello F.

Clin Cancer Res. 2013 Jul 1;19(13):3508-19. doi: 10.1158/1078-0432.CCR-12-2777. Epub 2013 May 21.

45.

Critical appraisal of the use of regorafenib in the management of colorectal cancer.

Festino L, Fabozzi A, Manzo A, Gambardella V, Martinelli E, Troiani T, De Vita F, Orditura M, Ciardiello F, Morgillo F.

Cancer Manag Res. 2013 Apr 12;5:49-55. doi: 10.2147/CMAR.S34281. Print 2013.

46.

Emerging VEGF-receptor inhibitors for colorectal cancer.

Martinelli E, Troiani T, Morgillo F, Orditura M, De Vita F, Belli G, Ciardiello F.

Expert Opin Emerg Drugs. 2013 Mar;18(1):25-37. doi: 10.1517/14728214.2013.749856. Epub 2012 Dec 6. Review.

PMID:
23216053
47.

Beyond bevacizumab: new anti-VEGF strategies in colorectal cancer.

Troiani T, Martinelli E, Orditura M, De Vita F, Ciardiello F, Morgillo F.

Expert Opin Investig Drugs. 2012 Jul;21(7):949-59. doi: 10.1517/13543784.2012.689287. Epub 2012 May 22. Review.

PMID:
22612461
48.

Targeting EGFR in pancreatic cancer treatment.

Troiani T, Martinelli E, Capasso A, Morgillo F, Orditura M, De Vita F, Ciardiello F.

Curr Drug Targets. 2012 Jun;13(6):802-10. Review.

PMID:
22458527
49.

Current status of targeted therapies in advanced gastric cancer.

De Vita F, Giuliani F, Silvestris N, Rossetti S, Pizzolorusso A, Santabarbara G, Galizia G, Colucci G, Ciardiello F, Orditura M.

Expert Opin Ther Targets. 2012 Apr;16 Suppl 2:S29-34. doi: 10.1517/14728222.2011.652616. Epub 2012 Mar 23. Review.

PMID:
22443228
50.

The Over-The-Scope-Clip (OTSC) system is effective in the treatment of chronic esophagojejunal anastomotic leakage.

Galizia G, Napolitano V, Castellano P, Pinto M, Zamboli A, Schettino P, Orditura M, De Vita F, Auricchio A, Mabilia A, Pezzullo A, Lieto E.

J Gastrointest Surg. 2012 Aug;16(8):1585-9. doi: 10.1007/s11605-012-1862-1. Epub 2012 Mar 7.

PMID:
22396090

Supplemental Content

Loading ...
Support Center